Drug intelligence / Profile preview

ermiao powder

Development stage
Preclinical
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Ermiao powder is a traditional Chinese herbal formula composed of two main ingredients: Phellodendron amurense bark (Huang Bo) and Atractylodes lancea rhizome (Cang Zhu)[2][3][4]. It was first described in 1481 AD in the "Essential Teachings of Zhu Dan Xi." Ermiao powder is primarily used to expel dampness and drain heat from the lower body ("Lower Burner") according to Traditional Chinese Medicine (TCM) theory[3]. Modern pharmacological studies indicate that Ermiao powder exerts anti-inflammatory effects by modulating immune pathways. Specifically, it has been shown to regulate the cholinergic anti-inflammatory pathway via downregulation of CHRNA7 (encoding α7 nicotinic acetylcholine receptor), as well as targeting key inflammatory signaling pathways such as PI3K-Akt, MAPK, TNF, and NF-κB[1][2]. The formula contains multiple active components including wogonin, paeonol, ethyl caffeate, and magnoflorine[2]. Its primary clinical indication is for conditions associated with damp-heat patterns such as rheumatoid arthritis; it may also be used for other inflammatory or pain-related disorders in TCM practice[1][2][3].

Brand names
Er Miao San GranulesTwo Marvels Powder
Other names
Er Miao SanTwo Marvel PowderPowder of Phellodendri and Atractylodis
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TNFA (Tumor necrosis factor alpha (soluble))CHRNA7 (α7 nicotinic receptor)

Beyond the preview

Go deeper on ermiao powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ermiao powder.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call